相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genome-Wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of TNFRSF11A and Identification of ZBTB10 and Three Distinct HLA Associations
Michael F. Seldin et al.
MOLECULAR MEDICINE (2015)
A Genome-Wide Association Study of Myasthenia Gravis
Alan E. Renton et al.
JAMA NEUROLOGY (2015)
Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis
Raffaele Iorio et al.
JOURNAL OF NEUROLOGY (2015)
EFNS/ENS Guidelines for the treatment of ocular myasthenia
E. Kerty et al.
EUROPEAN JOURNAL OF NEUROLOGY (2014)
Late-onset myasthenia gravis-CTLA4low genotype association and low-for-age thymic output of naive T cells
Wen-Yu Chuang et al.
JOURNAL OF AUTOIMMUNITY (2014)
A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis
P. Zisimopoulou et al.
JOURNAL OF AUTOIMMUNITY (2014)
LRP4 Is Critical for Neuromuscular Junction Maintenance
Arnab Barik et al.
JOURNAL OF NEUROSCIENCE (2014)
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial
Gavin Giovannoni et al.
LANCET NEUROLOGY (2014)
INTRAVENOUS IMMUNOGLOBULIN MAINTENANCE TREATMENT IN MYASTHENIA GRAVIS: A RANDOMIZED, CONTROLLED TRIAL SAMPLE SIZE SIMULATION
Christian Eienbroeker et al.
MUSCLE & NERVE (2014)
Anti-agrin autoantibodies in myasthenia gravis
Christiane Gasperi et al.
NEUROLOGY (2014)
Autoantibodies to Agrin in Myasthenia Gravis Patients
Bin Zhang et al.
PLOS ONE (2014)
Immunoadsorption in steroid-refractory multiple sclerosis
Michael J. Koziolek et al.
ATHEROSCLEROSIS SUPPLEMENTS (2013)
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes
Alexander Marx et al.
AUTOIMMUNITY REVIEWS (2013)
Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis
Chengyong Shen et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial
Ralf Gold et al.
LANCET (2013)
A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis
James F. Howard et al.
MUSCLE & NERVE (2013)
MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4
Maartje G. Huijbers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Risk for Myasthenia Gravis Maps to a 151Pro→Ala Change in TNIP1 and to Human Leukocyte Antigen-B*08
Peter K. Gregersen et al.
ANNALS OF NEUROLOGY (2012)
Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative Myasthenia Gravis
Bin Zhang et al.
ARCHIVES OF NEUROLOGY (2012)
Myasthenogenicity of the main immunogenic region and endogenous muscle nicotinic acetylcholine receptors
Jie Luo et al.
AUTOIMMUNITY (2012)
Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice
Rinse Klooster et al.
BRAIN (2012)
Impaired regulatory function in circulating CD4+CD25highCD127low/- T cells in patients with myasthenia gravis
Muthusamy Thiruppathi et al.
CLINICAL IMMUNOLOGY (2012)
Autoimmune mechanisms in myasthenia gravis
Paola Cavalcante et al.
CURRENT OPINION IN NEUROLOGY (2012)
Radioligand-Binding Assay Reveals Distinct Autoantibody Preferences for Type I Interferons in APS I and Myasthenia Gravis Subgroups
Liv Hapnes et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis
Alexandra Pevzner et al.
JOURNAL OF NEUROLOGY (2012)
Antibodies against the main immunogenic region of the acetylcholine receptor correlate with disease severity in myasthenia gravis
Tomoko Masuda et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
Jeffrey A. Cohen et al.
LANCET (2012)
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
Alasdair J. Coles et al.
LANCET (2012)
Long-lasting treatment effect of rituximab in MuSK myasthenia
J. Diaz-Manera et al.
NEUROLOGY (2012)
Mechanisms of Disease Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
Erwin W. Gelfand
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Late Onset Myasthenia Gravis Is Associated with HLA DRB1*15:01 in the Norwegian Population
Angelina H. Maniaol et al.
PLOS ONE (2012)
Pregnancy outcome after paternal exposure to azathioprine/6-mercaptopurine
Maria Hoeltzenbein et al.
REPRODUCTIVE TOXICOLOGY (2012)
Autoantibodies to Low-Density Lipoprotein Receptor-Related Protein 4 in Myasthenia Gravis
Osamu Higuchi et al.
ANNALS OF NEUROLOGY (2011)
A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis
Jeannine M. Heckmann et al.
BMC NEUROLOGY (2011)
Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: Clinical and pathogenetic implications
Kai Kisand et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
A randomized and controlled study comparing immunoadsorption and plasma exchange in myasthenic crisis
Wolfgang Koehler et al.
JOURNAL OF CLINICAL APHERESIS (2011)
Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis
Hiroaki Yoshikawa et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Five-year follow-up with low-dose tacrolimus in patients with myasthenia gravis
Naoya Minami et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
ANTI-MuSK ANTIBODY MYASTHENIA GRAVIS: CLINICAL FINDINGS AND RESPONSE TO TREATMENT IN TWO LARGE COHORTS
Jeffrey T. Guptill et al.
MUSCLE & NERVE (2011)
Administration of intravenous immunoglobulins in neurology. An evidence-based consensus: update 2010
M. Stangel et al.
NERVENARZT (2011)
Comparison of IVIg and PLEX in patients with myasthenia gravis
D. Barth et al.
NEUROLOGY (2011)
Evidence-based guideline update: Plasmapheresis in neurologic disorders Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
I. Cortese et al.
NEUROLOGY (2011)
Acetylcholinesterase inhibitor treatment for myasthenia gravis
Man Mohan Mehndiratta et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Immunotherapy for Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome Part 2: Intravenous Immunoglobulins and Apheresis Techniques
T. Henze et al.
AKTUELLE NEUROLOGIE (2010)
A systematic review of population based epidemiological studies in Myasthenia Gravis
Aisling S. Carr et al.
BMC NEUROLOGY (2010)
Guidelines for treatment of autoimmune neuromuscular transmission disorders
G. O. Skeie et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
MYCOPHENOLATE MOFETIL IN AChR-ANTIBODY-POSITIVE MYASTHENIA GRAVIS: OUTCOMES IN 102 PATIENTS
Michael K. Hehir et al.
MUSCLE & NERVE (2010)
Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis
Haochu Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Comparative Clinical Outcomes of Thymectomy for Myasthenia Gravis Performed by Extended Transsternal and Minimally Invasive Approaches
Dan M. Meyer et al.
ANNALS OF THORACIC SURGERY (2009)
Allogeneic Hematopoietic Cell Transplantation for Refractory Myasthenia Gravis
Jonathan Strober et al.
ARCHIVES OF NEUROLOGY (2009)
Long-term outcome of thoracoscopic extended thymectomy for nonthymomatous myasthenia gravis
Eugenio Pompeo et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2009)
Plasmapheresis for neurological disorders
Alexandra Schroeder et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Graded Response to Thymectomy in Children With Myasthenia Gravis
Molly M. Tracy et al.
JOURNAL OF CHILD NEUROLOGY (2009)
Juvenile Myasthenia Gravis: Three Case Reports and a Literature Review
Paul Gadient et al.
JOURNAL OF CHILD NEUROLOGY (2009)
Expanded TCR Vβ subsets of CD8+ T-cells in late-onset myasthenia gravis: Novel parallels with thymoma patients
B. Tackenberg et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up
Mark J. Kupersmith
JOURNAL OF NEUROLOGY (2009)
Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function
Edson X. Albuquerque et al.
PHYSIOLOGICAL REVIEWS (2009)
MYCOPHENOLATE MOFETIL AS SECOND LINE IMMUNOSUPPRESSANT IN MYASTHENIA GRAVIS - A LONG-TERM PROSPECTIVE OPEN-LABEL STUDY
F. Hanisch et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2009)
Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction
Rebecca N. Cole et al.
ANNALS OF NEUROLOGY (2008)
Tacrolimus for myasthenia gravis - A clinical study of 212 patients
Jose M. Ponseti et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
Autoimmunizing mechanisms in thymoma and thymus
Nick Willcox et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
Response to therapy in myasthenia gravis with anti-MuSK antibodies
Amelia Evoli et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis - Role of MHC class II and AIRE genes and genetic polymorphisms
Philipp Stroebel et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
Rebooting the immune system with high-dose cyclophosphamide for treatment of refractory myasthenia gravis
Daniel B. Drachman et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis
Maria Isabel Leite et al.
BRAIN (2008)
Long-term treatment of steroid-dependent myasthenia gravis patients with low-dose tacrolimus
Akiko Nagaishi et al.
INTERNAL MEDICINE (2008)
Preferential expression of AChR ε-subunit in thymomas from patients with myasthenia gravis
Calman A. MacLennan et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
The ageing and myasthenic thymus: A morphometric study validating a standard procedure in the histological workup of thymic specimens
Philipp Stroebel et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Corticosteroids and plasma exchange in multiple sclerosis
Hayretin Tumani
JOURNAL OF NEUROLOGY (2008)
A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis
NEUROLOGY (2008)
An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis
D. B. Sanders et al.
NEUROLOGY (2008)
Long-term outcome and quality of life after open and thoracoscopic thymectomy for myasthenia gravis: analysis of 131 patients
Kai Bachmann et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2008)
Intravenous immunoglobulin for myasthenia gravis
P. Gajdos et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Rescue therapy with anti-CD20 treatment in neuroimmunologic breakthrough disease
Andrew Chan et al.
JOURNAL OF NEUROLOGY (2007)
An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus
Matthieu Giraud et al.
NATURE (2007)
Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome
Jordi Diaz-Manera et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2007)
Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features
F. Romi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Thiopurine methyltransferase activity in Spain:: A study of 14,545 patients
Javier P. Gisbert et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type I (APS-I)
P. Stroebel et al.
JOURNAL OF PATHOLOGY (2007)
Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells
Katharina Aschenbrenner et al.
NATURE IMMUNOLOGY (2007)
IV immunoglobulin in patients with myasthenia gravis - A randomized controlled trial
Lorne Zinman et al.
NEUROLOGY (2007)
Immunosuppressive agents for myasthenia gravis
I. K. Hart et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
Clinical predictors of steroid-induced exacerbation in myasthenia gravis
Jong Seok Bae et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2006)
Long-terms therapeutic efficacy and safety of low-dose tacrolimus (FK506) for myasthenia gravis
Masayoshi Tada et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Long-term effects of a multimodal approach including immunoadsorption for the treatment of myasthenic crisis
Heike Zeitler et al.
ARTIFICIAL ORGANS (2006)
Myasthenia gravis in children: a longitudinal study
V. V. Ashraf et al.
ACTA NEUROLOGICA SCANDINAVICA (2006)
Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for musk antibody
Anna Rostedt Punga et al.
MUSCLE & NERVE (2006)
Induction of myasthenia by immunization against muscle-specific kinase
K Shigemoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies
PT Lin et al.
MUSCLE & NERVE (2006)
Treatment of Myasthenia Gravis exacerbation with intravenous immunoglobulin - A randomized double-blind clinical trial
P Gajdos et al.
ARCHIVES OF NEUROLOGY (2005)
Azathioprine and UVA light generate mutagenic oxidative DNA damage
P O'Donovan et al.
SCIENCE (2005)
Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil
S Vernino et al.
NEUROLOGY (2005)
Effects of cytokines on acetylcholine receptor expression:: Implications for myasthenia gravis
S Poëa-Guyon et al.
JOURNAL OF IMMUNOLOGY (2005)
Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis
JM Ponseti et al.
NEUROLOGY (2005)
Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG
MI Leite et al.
ANNALS OF NEUROLOGY (2005)
Long-term treatment of generalised myasthenia gravis with FK506 (tacrolimus)
T Konishi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Thymus changes in anti-MuSK-positive and -negative myasthenia gravis
L Lauriola et al.
NEUROLOGY (2005)
Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis
H Shiraishi et al.
ANNALS OF NEUROLOGY (2005)
Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis
A Balandina et al.
BLOOD (2005)
Efficacy of low-dose FK506 in the treatment of myasthenia gravis - A randomized pilot study
Y Nagane et al.
EUROPEAN NEUROLOGY (2005)
Corticosteroids for myasthenia gravis - art. no. CD002828.pub2
C Scheider-Gold et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)
Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas:: A retrospective analysis
P Ströbel et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Detection and characterization of MuSK antibodies in seronegative myasthenia gravis
J McConville et al.
ANNALS OF NEUROLOGY (2004)
Response of thymectomy:: clinical and pathological characteristics among seronegative and seropositive myasthenia gravis patients
GR Guillermo et al.
ACTA NEUROLOGICA SCANDINAVICA (2004)
Selective loss of regulatory T cells in thymomas
P Ströbel et al.
ANNALS OF NEUROLOGY (2004)
Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients
L Zhou et al.
MUSCLE & NERVE (2004)
Repetitive nerve stimulation in myasthenia gravis -: relative sensitivity of different muscles
J Costa et al.
CLINICAL NEUROPHYSIOLOGY (2004)
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis
A Evoli et al.
BRAIN (2003)
Clinical aspects of MuSK antibody positive seronegative MG
DB Sanders et al.
NEUROLOGY (2003)
CD45 isoform expression in autoimmune myasthenia gravis
B Tackenberg et al.
AUTOIMMUNITY (2003)
Treatment of refractory myasthenia: Rebooting with high-dose cyclophosphamide
DB Drachman et al.
ANNALS OF NEUROLOGY (2003)
Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4+ T cells in thymomas
P Ströbel et al.
BLOOD (2002)
Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules
F Romi et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis
LG De Feo et al.
MUSCLE & NERVE (2002)
Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesis
I Roxanis et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Successful treatment of myasthenia gravis with tacrolimus
A Evoli et al.
MUSCLE & NERVE (2002)
Induction, assembly, maturation and maintenance of a postsynaptic apparatus
JR Sanes et al.
NATURE REVIEWS NEUROSCIENCE (2001)
Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis
C Buckley et al.
ANNALS OF NEUROLOGY (2001)
Presentation by myoblasts of an epitope from endogenous acetylcholine receptor indicates a potential role in the spreading of the immune response
J Curnow et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
W Hoch et al.
NATURE MEDICINE (2001)
Mycophenolate mofetil for myasthenia gravis: An open-label pilot study
E Ciafaloni et al.
NEUROLOGY (2001)
Immunosuppressive treatment of ocular myasthenia gravis
B Tackenberg et al.
BIODRUGS (2001)
Clinical characteristics and prognosis of myasthenia gravis in older people
A Evoli et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2000)
Practice parameter: Thymectomy for autoimmune myasthenia gravis (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
GS Gronseth et al.
NEUROLOGY (2000)
Comparison between double-filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis
JH Yeh et al.
JOURNAL OF NEUROLOGY (2000)
分享论文
